Patent · US Active

Lenalidomide and thalidomide immunoassays

US8440796B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Saladax Biomedical Inc. · US

Inventors

Salvatore J. Salamone · Stockton, US
Jodi Blake Courtney · Doylestown, US
Alexander Volkov · Sunnyvale, US
Howard Sard · Arlington, US
Vishnumurthy Hegde · Chelmsford, US

Key dates

Filing date	Nov 23, 2011
Grant date	May 14, 2013
Priority date	—
Expiry date	Nov 23, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S436/815
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Novel conjugates and immunogens derived from lenalidomide and antibodies generated by these immunogens are useful in immunoassays for the quantification and monitoring of thalidomide and lenalidomide in biological fluids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.